BT
Black Arrow Biotech develops anti-cancer peptide (ACP) drugs by employing computational techniques to identify novel peptides that target cancer cells. The company focuses on addressing the complexities of cancer treatment through its expertise in pharmaceutical and biotech research.
Updated 5 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Black Arrow Biotech develops anti-cancer peptide (ACP) drugs by employing computational techniques to identify novel peptides that target cancer cells. The company focuses on addressing the complexities of cancer treatment through its expertise in pharmaceutical and biotech research.